Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Perry, M.
Right arrow Articles by Chew-Graham, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perry, M.
Right arrow Articles by Chew-Graham, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Family Practice Vol. 20, No. 5, 538-544
© Oxford University Press 2003


Information in practice

Finding a vein or obtaining consent: a qualitative study of hepatitis C testing in GP methadone clinics

Mark Perry and Carolyn Chew-Graham

School of Primary Care, University of Manchester, Rusholme Health Centre, Walmer Street, Manchester M14 5NP, UK.

Correspondence to Mark Perry; E-mail: msperry{at}man.ac.uk

Background. Informed consent is a professional norm, but the promotion of testing for infectious disease in organized clinics and the introduction of targets for uptake, such as those for human immunodeficiency virus (HIV) testing in antenatal clinics, might impair truly voluntary consent. Hepatitis C virus (HCV) is highly prevalent among intravenous drug users (IDUs) and the ‘offer’ of a serological test for HCV antibodies is now seen as a national standard within drug misuse services, including GP methadone clinics. We hoped that GPs’ descriptions of the context and offer of HCV testing could provide an exploratory study of consent within primary care clinics.

Objectives. The aim of this study was to understand GPs’ ethical practice when negotiating consent to HCV testing with IDUs.

Method. A qualitative semi-structured interview study of 20 GPs in Greater Manchester was carried out.

Results. GPs reported that they or their attached drug workers commonly tested for HCV, and many stressed the need for good teamwork and building relationships with ‘stable’ IDUs before testing. GPs’ views on the beneficence of testing and their practices in obtaining consent were diverse. GPs’ discourse highlighted important management problems: (i) the adequacy of preparation of some IDUs for testing; (ii) ‘opportunistic’ HCV testing; and (iii) GPs’ recognition of denial after testing. While GPs offered little explicit ethical reflection, occasionally they remarked on tendencies to control a patient’s decision, and a deviant case analysis demonstrates how poor teamwork can be associated with coercion.

Conclusion. GPs’ descriptions suggest that an effective informed consent process is the norm for HCV testing within GP methadone clinics. Importantly, a minority of GPs alluded to the directive effect of team protocols or other problems in obtaining valid consent. We offer recommendations for managing testing to ensure voluntary choice.

Keywords. Coercion, hepatitis C, informed consent, primary health care, substance abuse, intravenous.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.